Drug Profile
Research programme: antiviral vaccines - Organic Vaccines
Latest Information Update: 24 Jul 2023
Price :
$50
*
At a glance
- Originator Organic Vaccines
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Human papillomavirus infections; Influenza virus infections
Most Recent Events
- 24 Jul 2023 Discontinued - Preclinical for Human papillomavirus infections in France (Parenteral)
- 24 Jul 2023 Discontinued - Preclinical for Influenza virus infections in France (Parenteral)
- 28 Jan 2019 No recent reports of development identified for preclinical development in Human-papillomavirus-infections in France (Parenteral)